Literature DB >> 16538887

A randomized controlled trial to determine whether treatment with at neutral pH, low glucose degradation product dialysate (balance) prolongs residual renal function in peritoneal dialysis patients.

F Brown, D W Johnson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16538887

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


× No keyword cloud information.
  2 in total

Review 1.  Effect of biocompatible peritoneal dialysis solution on residual renal function: a systematic review of randomized controlled trials.

Authors:  Eun-Young Seo; Sook Hee An; Jang-Hee Cho; Hae Sun Suh; Sun-Hee Park; Hyesun Gwak; Yong-Lim Kim; Hunjoo Ha
Journal:  Perit Dial Int       Date:  2014-09-02       Impact factor: 1.756

2.  Biocompatible dialysis fluids for peritoneal dialysis.

Authors:  Htay Htay; David W Johnson; Kathryn J Wiggins; Sunil V Badve; Jonathan C Craig; Giovanni Fm Strippoli; Yeoungjee Cho
Journal:  Cochrane Database Syst Rev       Date:  2018-10-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.